New Applications of Heparin and Other Glycosaminoglycans
AbstractHeparin, the widely used pharmaceutical anticoagulant, has been in clinical use for well over half a century. Its introduction reduced clotting risks substantially and subsequent developments, including the introduction of low-molecular-weight heparin, made possible many major surgical interventions that today make heparin an indispensable drug. There has been a recent burgeoning of interest in heparin and related glycosaminoglycan (GAG) polysaccharides, such as chondroitin sulfates, heparan sulfate, and hyaluronate, as potential agents in various applications. This ability arises mainly from the ability of GAGs to interact with, and alter the activity of, a wide range of proteins. Here, we review new developments (since 2010) in the application of heparin and related GAGs across diverse fields ranging from thrombosis and neurodegenerative disorders to microbiology and biotechnology. View Full-Text
A printed edition of this Special Issue is available here.
Share & Cite This Article
Lima, M.; Rudd, T.; Yates, E. New Applications of Heparin and Other Glycosaminoglycans. Molecules 2017, 22, 749.
Lima M, Rudd T, Yates E. New Applications of Heparin and Other Glycosaminoglycans. Molecules. 2017; 22(5):749.Chicago/Turabian Style
Lima, Marcelo; Rudd, Timothy; Yates, Edwin. 2017. "New Applications of Heparin and Other Glycosaminoglycans." Molecules 22, no. 5: 749.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.